{"title":"pde4抑制剂的肽结合位点模型","authors":"E. Polymeropoulos, N. Höfgen","doi":"10.1002/(SICI)1521-3838(199912)18:6<543::AID-QSAR543>3.0.CO;2-V","DOIUrl":null,"url":null,"abstract":"Selective inhibitors of the isoenzyme phosphodiesterase 4 (PDE 4) have attracted increased interest in the last few years as potential drugs for the treatment of allergic diseases such as asthmal,2.","PeriodicalId":20818,"journal":{"name":"Quantitative Structure-activity Relationships","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"A Peptidic Binding Site Model for PDE 4 Inhibitors\",\"authors\":\"E. Polymeropoulos, N. Höfgen\",\"doi\":\"10.1002/(SICI)1521-3838(199912)18:6<543::AID-QSAR543>3.0.CO;2-V\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Selective inhibitors of the isoenzyme phosphodiesterase 4 (PDE 4) have attracted increased interest in the last few years as potential drugs for the treatment of allergic diseases such as asthmal,2.\",\"PeriodicalId\":20818,\"journal\":{\"name\":\"Quantitative Structure-activity Relationships\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1999-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Quantitative Structure-activity Relationships\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/(SICI)1521-3838(199912)18:6<543::AID-QSAR543>3.0.CO;2-V\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Quantitative Structure-activity Relationships","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/(SICI)1521-3838(199912)18:6<543::AID-QSAR543>3.0.CO;2-V","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A Peptidic Binding Site Model for PDE 4 Inhibitors
Selective inhibitors of the isoenzyme phosphodiesterase 4 (PDE 4) have attracted increased interest in the last few years as potential drugs for the treatment of allergic diseases such as asthmal,2.